Jacqueline Miller is a pediatrician who graduated from Northwestern University’s Feinberg School of Medicine, and trained at the Children’s Hospital of Philadelphia. For the past 20 years, she has worked in the field of Vaccine Development, contributing to the licensure of 5 vaccines targeting populations ranging from infants to older adults. She joined Moderna in 2020 as the Therapeutic Area Head for Infectious Diseases, and currently leads the medical teams developing Moderna’s vaccines and monoclonal antibodies directed against infectious pathogens. Prior to joining Moderna, she was most recently Head, Clinical R&D, US R&D Center at GlaxoSmithKline. She is pleased to take this opportunity to provide an update with respect to Moderna’s mRNA-1273 program.